Published Feb 2024

The Patrick Wild Centre is currently running the RECONNECT clinical trial for children and adolescents with fragile X syndrome.

The link below will take you to a website with more information about the trial and a place to enter your details if you are thinking of participating.  Or feel free to just contact us directly at

Learn more about a clinical trial evaluating investigational topical cannabidiol (CBD) gel to see if it helps behavioural issues related to Fragile X syndrome.

Potential participants need to be:

  • Between 3 and 17 years of age
  • Diagnosed via genetic testing, with Fragile X syndrome
  • In generally good health

Follow the link to find out more: Reconnect Fragile X Syndrome Research Study in UK | Zynerba (

Make a Donation Today!

Heart Donation